COMMUNIQUÉS West-GlobeNewswire

Solon Eiendom ASA : Primary insider notification

12/06/2018 - 08:30

(Oslo, Norway, June 11, 2018) UFI AS has today bought 15.145 shares in Solon Eiendom ASA at a price of NOK 30.027 per share. Solon Eiendom ASA Board Member Øystein A. Landvik owns 33,34 % of the shares in UFI AS. [...]

Shire plc : Rule 2.9 Announcement

12/06/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 12 June 2018 Shire [...]

FIT Biotech Oy: First EHVA clinical trial authorization granted for testing FIT-06

12/06/2018 - 07:31

FIT Biotech Oy Company release 12.6.2018 at 8:30 AM EET First EHVA clinical trial authorization granted for testing FIT-06 FIT Biotech Oy ("Company", FITBIO: FN Finland) today announced that the Swiss medical [...]

European Select Growth Opportunities Fund subscribes to the 19th tranche of its investment today and has agreed to provide up to EUR 7.25 million in additional funding

12/06/2018 - 07:18

Amsterdam, The Netherlands - 12 June 2018 Esperite N.V. (Euronext: ESP, " Esperite " or the " Group ") announces today the issuance to European Select Growth Opportunities Fund (the " Investor " or " ESGO ") of the 19th [...]

Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2018

12/06/2018 - 07:01

Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2018 Amsterdam, the Netherlands, San Diego, CA, USA and Holzgerlingen, Germany , June 12, 2018 , 01:00 a.m. EST -- Curetis N.V. (the " [...]

Santhera Submits NDA in South Korea for Raxone® for the Treatment of LHON

12/06/2018 - 07:01

Pratteln, Switzerland, June 12, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that the Korean Ministry of Food and Drug Safety (MFDS) has accepted for review Santhera's new drug application (NDA) for Raxone® ( [...]

argenx to host KOL breakfast symposium on immune thrombocytopenia on June 19, 2018

12/06/2018 - 07:01

June 12, 2 018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]

Acasti Pharma Reports on Positive Feedback Following Today’s Presentation at the XVIII International Symposium on Atherosclerosis

12/06/2018 - 02:07

LAVAL, Québec, June 11, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ:ACST) (TSX-V:ACST) (the “ Company ” or “ Acasti Pharma ”), a biopharmaceutical innovator focused on the research, development and [...]

Compass Cannabis Clinics Launches International Venture

12/06/2018 - 00:35

CALGARY, Alberta, June 11, 2018 (GLOBE NEWSWIRE) -- 10330698 Canada Ltd. (dba Compass Cannabis Clinics, "Compass") is pleased to announce that it has entered into a letter of intent with Dr. Teresa Towpik which will [...]

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12/06/2018 - 00:10

CAMBRIDGE, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat [...]

IntelGenx Grants Stock Options

11/06/2018 - 23:39

SAINT LAURENT, Quebec, June 11, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. ("IntelGenx", or the “Company”) (TSX-V:IGX) (OTCQX:IGXT) announced today that the Company’s board of directors granted options to [...]

Project HOPE Responds to Urgent Health Needs from Guatemala’s Fuego Volcano

11/06/2018 - 23:36

Millwood, VA, June 11, 2018 (GLOBE NEWSWIRE) -- Project HOPE announced the deployment of an emergency medical response team to Guatemala as fresh lava flows from the Fuego volcano, prolonging a disaster that has [...]

N.M. Judge Rejects NMDOH Sanction for Seedling at State Fair

11/06/2018 - 23:13

Judge David K. Thomson rules NMDOH sanction is arbitrary and capricious SANTA FE, N.M., June 11, 2018 (GLOBE NEWSWIRE) -- District Judge David. K Thomson reversed the New Mexico Department of Health (NMDOH) sanction [...]

Surface Oncology to be Added to the Russell 3000 Index and Russell 2000 Index

11/06/2018 - 23:07

CAMBRIDGE, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]

Clearside Biomedical to Participate in 2018 JMP Securities Life Sciences Conference

11/06/2018 - 23:00

ALPHARETTA, Ga., June 11, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

AMAG Pharmaceuticals, Inc. and March of Dimes Announce Collaboration to Improve Health of Mothers and Babies

11/06/2018 - 22:44

WALTHAM, Mass. and WHITE PLAINS, N.Y., June 11, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) and March of Dimes today announced a strategic corporate partnership focused on a shared commitment to [...]

PLx Pharma Inc. to Present at JMP Securities Life Sciences Conference

11/06/2018 - 22:30

HOUSTON, June 11, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 mg [...]

Optinose Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Common Shares

11/06/2018 - 22:25

YARDLEY, Pa., June 11, 2018 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), announced today the closing of its underwritten public offering of 5,750,000 of its common shares at a price to the public of $22.25 per [...]

Immunomedics Announces Proposed Public Offering of Common Stock

11/06/2018 - 22:13

MORRIS PLAINS, N.J., June 11, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]